GUEST COLUMNISTS

• Patient Weighs Altruism, Self-Preservation, And Historical Mistrust In Decision To Enroll In Trial

  In part three of this series on underserved patient enrollment, patient advocate Bill Allen shares why he enrolled in a clinical trial for both himself and the Black community.

• Enrollment Mishap Emboldens Patient To Advocate For Minority Participation

  In part two of this series on underserved patient enrollment, PAN Foundation patient advocate Tony Newberne shares how narrowly missed trial enrollment and how the experience inspired him to advocate for clinical research in minority communities.

• The PAN Foundation Expands Resources For Underserved Patient Populations

  In part one of this series on underserved patient enrollment, PAN Foundation CMO Amy Niles discusses the Foundation's efforts to improve access to and affordable healthcare for (including in clinical research) underserved patient populations.

• UCB Emphasizes Importance Of Patient-Centric Protocols

  UCB Global Medical Head of Immunology John Ioannou emphasizes the need to partner with the healthcare community, supporting medical and patient organizations, but most importantly, patients to advance the design and execution of patient-centric clinical trials.

• How Changes To The Declaration Of Helsinki Impact Clinical Trials

  Consultant Jessica Cordes breaks down the latest version of the Declaration of Helsinki and how it builds upon the previous version from 2013.

• Scaling Gene Therapy Clinical Trials Through The Lens Of Ophthalmology

  Ocugen CMO Huma Qamar, MD, MPH, CMI discusses scaling gene therapy clinical trials with special attention paid to logistical planning, collaboration with specialized centers, and managing future manufacturing needs.

• The One-And-Done Investigator: A Clinical Trial Story

  There are too many one-and-done principal investigators in clinical research — at least that's the common refrain. But Paul Ivsin isn't convinced. Here, Ivsin looks into and discusses the supposed one-and-done PI crisis.

• CRO Summit Chair Muses On The Future Of CROs

  Clinical Outsourcing Group CRO Summit Chair and seasoned biopharma CxO Jasmina Jankicevic shares her insights on the evolving landscape of CROs.